Adicet Bio (ACET) Short Interest Ratio & Short Volume → The AI Stock that’s Disrupting Every Industry (From StockEarnings) (Ad) Free ACET Stock Alerts $1.41 -0.11 (-7.24%) (As of 05/2/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Adicet Bio Short Interest DataCurrent Short Volume7,850,000 sharesPrevious Short Volume7,690,000 sharesChange Vs. Previous Month+2.08%Dollar Volume Sold Short$17.27 millionShort Interest Ratio / Days to Cover5.5Last Record DateApril 15, 2024Outstanding Shares82,170,000 sharesPercentage of Shares Shorted9.55%Today's Trading Volume4,726,438 sharesAverage Trading Volume964,546 sharesToday's Volume Vs. Average490% Short Selling Adicet Bio ? Sign up to receive the latest short interest report for Adicet Bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatACET Short Interest Over TimeACET Days to Cover Over TimeACET Percentage of Float Shorted Over Time Ad StockEarningsThe AI stock to buy right nowThere are about 350,000 large corporations worldwide. Can you see the potential for this AI company to grow like crazy?Click Here to Get the AI Stock Name Adicet Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20247,850,000 shares $17.27 million +2.1%N/A5.5 $2.20 3/31/20247,690,000 shares $18.07 million +32.4%N/A4.6 $2.35 3/15/20245,810,000 shares $11.62 million +2.7%N/A3.4 $2.00 2/29/20245,660,000 shares $13.30 million +19.2%N/A3.7 $2.35 2/15/20244,750,000 shares $14.25 million +22.1%N/A3.4 $3.00 1/31/20243,890,000 shares $11.63 million +21.2%N/A3.4 $2.99 Get the Latest News and Ratings for ACET and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Adicet Bio and its competitors with MarketBeat's FREE daily newsletter. 1/15/20243,210,000 shares $10.69 million +21.1%10.6%3.8 $3.33 12/31/20232,650,000 shares $5.01 million +4.7%8.7%4.3 $1.89 12/15/20232,530,000 shares $4.02 million -18.9%8.3%6.4 $1.59 11/30/20233,120,000 shares $3.68 million +3.0%10.3%8.4 $1.18 11/15/20233,030,000 shares $3.67 million +6.7%10.0%7.7 $1.21 10/31/20232,840,000 shares $3.75 million -5.7%9.5%6.5 $1.32 10/15/20233,010,000 shares $4.15 million +0.3%10.0%6.6 $1.38 9/30/20233,000,000 shares $4.11 million +2.4%10.0%6.1 $1.37 9/15/20232,930,000 shares $5.01 million +8.5%9.7%3.3 $1.71 8/31/20232,700,000 shares $5.40 million +9.3%9.0%2.9 $2.00 8/15/20232,470,000 shares $5.26 million +7.4%8.2%2.7 $2.13 7/31/20232,300,000 shares $6.14 million -22.3%7.4%2.6 $2.67 7/15/20232,960,000 shares $9.12 million -5.7%9.6%3.5 $3.08 6/30/20233,140,000 shares $7.63 million -12.3%10.2%3.8 $2.43 6/15/20233,580,000 shares $16.22 million +15.1%12.0%8.2 $4.53 5/31/20233,110,000 shares $17.04 million +6.1%10.4%6.7 $5.48 5/15/20232,930,000 shares $20.89 million -7.6%9.8%6.2 $7.13 4/30/20233,170,000 shares $18.51 million +16.1%11.4%6.6 $5.84 4/15/20232,730,000 shares $15.32 million -2.9%9.1%5.5 $5.61 3/31/20232,810,000 shares $16.19 million -7.6%9.4%5.3 $5.76 3/15/20233,040,000 shares $23.44 million -7.6%10.2%5.4 $7.71 2/28/20233,290,000 shares $25.93 million -4.1%11.0%4.7 $7.88 2/15/20233,430,000 shares $27.92 million +7.9%11.5%4.8 $8.14 1/31/20233,180,000 shares $29.10 million -15.2%11.0%4.2 $9.15 1/15/20233,750,000 shares $32.59 million -1.8%12.9%4.9 $8.69 12/30/20223,820,000 shares $34.15 million -6.8%13.1%5.1 $8.94 12/15/20224,100,000 shares $40.80 million +2.0%14.1%5.5 $9.95 11/30/20224,020,000 shares $73.08 million +29.7%14.2%6.7 $18.18 11/15/20223,100,000 shares $63.05 million -13.7%11.0%5.6 $20.34 10/31/20223,590,000 shares $59.20 million -4.8%13.6%6.5 $16.49 10/15/20223,770,000 shares $62.62 million -4.8%14.2%7.2 $16.61 9/30/20223,960,000 shares $56.31 million +30.3%15.0%7.6 $14.22 9/15/20223,040,000 shares $52.08 million +8.2%11.5%6 $17.13 8/31/20222,810,000 shares $39.79 million +10.6%11.7%5.8 $14.16The Long-Awaited End of America Update (Ad)A 995% Gain Last Time We Shared this "Election Secret" It's a straightforward way to come out on top no matter who wins this November… It's not cryptos, or options, and anyone can do it.Click here to find out for free. ACET Short Interest - Frequently Asked Questions What is Adicet Bio's current short interest? Short interest is the volume of Adicet Bio shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 7,850,000 shares of ACET short. Learn More on Adicet Bio's current short interest. What is a good short interest ratio for Adicet Bio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ACET shares currently have a short interest ratio of 6.0. Learn More on Adicet Bio's short interest ratio. Which institutional investors are shorting Adicet Bio? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Adicet Bio: Concourse Financial Group Securities Inc., Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Adicet Bio's short interest increasing or decreasing? Adicet Bio saw a increase in short interest in April. As of April 15th, there was short interest totaling 7,850,000 shares, an increase of 2.1% from the previous total of 7,690,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Adicet Bio's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Adicet Bio: PDS Biotechnology Co. (19.47%), Amylyx Pharmaceuticals, Inc. (13.87%), Sagimet Biosciences Inc. (12.02%), Karyopharm Therapeutics Inc. (20.23%), Cartesian Therapeutics, Inc. (45.28%), Citius Pharmaceuticals, Inc. (8.29%), Societal CDMO, Inc. (0.00%), GlycoMimetics, Inc. (4.67%), Repare Therapeutics Inc. (2.13%), Vistagen Therapeutics, Inc. (5.31%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Adicet Bio stock? Short selling ACET is an investing strategy that aims to generate trading profit from Adicet Bio as its price is falling. ACET shares are trading down $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Adicet Bio? A short squeeze for Adicet Bio occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ACET, which in turn drives the price of the stock up even further. How often is Adicet Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACET, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: PDSB Short Interest Data AMLX Short Interest Data SGMT Short Interest Data KPTI Short Interest Data RNAC Short Interest Data CTXR Short Interest Data SCTL Short Interest Data GLYC Short Interest Data RPTX Short Interest Data VTGN Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ACET) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldThe AI stock to buy right nowStockEarningsCould Your Accounts Be Frozen?Allegiance GoldHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmith$5,000 Gold?Stansberry ResearchBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press